Ortin Global Limited (NSE:ORTINGLOBE)

Market Cap	93.19M
Revenue (ttm)	4.42M
Net Income (ttm)	-48.27M
Shares Out	n/a
EPS (ttm)	-5.94
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	527
Average Volume	21,970
Open	11.13
Previous Close	11.12
Day's Range	11.13 - 11.58
52-Week Range	9.64 - 23.90
Beta	1.37
RSI	50.88
Earnings Date	May 30, 2025

About Ortin Global

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. It operates through Manufacture and Trading segments. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides. Its formulations also...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1986
• Employees: 2
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ORTINGLOBE

Financial Performance

In 2023, Ortin Global's revenue was 21.12 million, a decrease of -64.93% compared to the previous year's 60.20 million. Losses were -80.41 million, 8490.8% more than in 2022.